Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 2,001–2,050 of 2,679 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02811523	In Vivo Lung Perfusion for Pulmonary Metastases of Sarcoma	recruiting	Phase 1	17	University Health Network, TorontoOTHER	1	Nov 26, 2025	clinicaltrials
NCT06316427	Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies	recruiting	Phase 1 / Phase 2	80	Beijing GoBroad HospitalOTHER	1	Nov 26, 2025	clinicaltrials